arrow_back Back to App

Splitting the National Institute of Allergy and Infectious Diseases into three research bodies

This Act divides the existing National Institute of Allergy and Infectious Diseases (NIAID) into three new research institutes: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases. The change aims to separate research on allergies, infectious diseases, and immunologic disorders. Directors of the new institutes will be appointed by the President with the advice and consent of the Senate for 5-year terms.
Key points
The single NIAID is replaced by three separate bodies: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases.
Directors of the three new institutes will be appointed by the President and confirmed by the Senate for 5-year terms (renewable once).
Research on infectious diseases (including tropical diseases), allergic diseases, and immunologic disorders will be separated among the new institutes.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_960
Sponsor: Sen. Paul, Rand [R-KY]
Process start date: 2023-03-23
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

NIH Reform Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_960.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-03-23.

What are the main provisions?

Key points include:

  • The single NIAID is replaced by three separate bodies: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases.
  • Directors of the three new institutes will be appointed by the President and confirmed by the Senate for 5-year terms (renewable once).
  • Research on infectious diseases (including tropical diseases), allergic diseases, and immunologic disorders will be separated among the new institutes.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Paul, Rand [R-KY].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

CATEGORIES

Health